Vancomycin 1.75gm/350ml Inj, 350ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is typically administered as an infusion into a vein over a period of time. In some cases, it may be given orally or through a feeding tube instead of as an injection, if deemed necessary by your healthcare provider.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist for guidance on proper storage.
Missing a Dose
If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- Stay well-hydrated to help your kidneys function properly.
- Report any new or worsening symptoms to your healthcare provider immediately.
- Avoid alcohol if it causes stomach upset or other issues, though no direct interaction is known.
- Complete the full course of treatment, even if you start feeling better, to prevent antibiotic resistance.
Available Forms & Alternatives
Available Strengths:
- Vancomycin 1000mg Inj
- Vancomycin 500mg Vial Forinjection
- Vancomycin 500mg Inj, 1 Vial
- Vancomycin 10gm Inj, 1 Vial
- Vancomycin 5gm Inj, 1 Vial
- Vancomycin 1000mg Inj (ad-Vantage)
- Vancomycin 5gm Inj, 1 Vial
- Vancomycin 750mg Inj, 1 Vial
- Vancomycin 1gm Inj, 1 Vial
- Vancomycin 125mg Capsules
- Vancomycin 250mg Capsules
- Vancomycin 1gm/200m Inj 12x200ml
- Vancomycin 250mg/5ml Oral Solution
- Vancomycin 10gm Inj, 1 Vial
- Vancomycin 1.25gm Inj 1 Vial
- Vancomycin 25mg/ml Oral Soln 300ml
- Vancomycin 25mg/ml Oral Soln 150ml
- Vancomycin 25mg/ml Oral Soln 300ml
- Vancomycin 25mg/ml Oral Soln 150ml
- Vancomycin 50mg/ml Oral Solution
- Vancomycin 1.5mg Inj, 1 Vial
- Vancomycin 1.75gm/350ml Inj, 350ml
- Vancomycin 750mg/150ml Inj, 150ml
- Vancomycin 1.5gm/300ml Inj, 300ml
- Vancomycin 500mg/100ml Inj, 100ml
- Vancomycin 125mg Capsules
- Vancomycin 250mg Capsules
- Vancomycin Hcl 1.75gm Inj, 1 Vial
- Vancomycin Hcl 2gm Sdv Inj, 1 Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Severe skin reactions, such as:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect body organs and be life-threatening
+ Symptoms may include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands
If you receive this medication through injection (intravenous):
+ Fever
+ Chills
+ Sore throat
+ Pain when passing urine
+ Change in balance
+ Flushing
+ Rash on the face, neck, trunk, and arms during infusion
If the medication is administered too quickly, you may experience:
+ Shortness of breath or wheezing
+ Itching
+ Muscle pain
+ Chest pain
+ Signs of low blood pressure, such as dizziness or fainting
If the medication leaks from the vein, it can cause tissue damage. Inform your nurse immediately if you experience:
+ Redness
+ Burning
+ Pain
+ Swelling
+ Blisters
+ Skin sores
+ Leaking of fluid at the injection site
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, contact your doctor or seek medical attention if they bother you or persist:
Diarrhea
Stomach pain
Upset stomach
Vomiting
This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Redness, itching, or rash, especially on the upper body, during or shortly after infusion (Red Man Syndrome)
- Hearing changes, ringing in the ears (tinnitus), or dizziness (vertigo)
- Decreased urine output, swelling in legs/feet, unusual tiredness (signs of kidney problems)
- Fever, chills, sore throat (signs of new infection or blood disorder)
- Unusual bleeding or bruising
- Severe diarrhea (could be C. difficile infection, even after stopping vancomycin)
- Pain, redness, or swelling at the injection site
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
Potential interactions with other medications or health conditions. This medication may affect or be affected by other drugs or health problems, so it is crucial to disclose all relevant information.
To ensure safe use, provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter (OTC) medications you are taking
Natural products and vitamins you are using
* Any existing health problems
Carefully review your medications and health conditions to confirm that it is safe to take this medication in conjunction with them. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
If you have a history of kidney problems, such as kidney failure, notify your doctor, as this medication can cause kidney issues. Your doctor will likely recommend regular blood tests and other laboratory evaluations to monitor your condition.
Long-term use of this medication may increase the risk of permanent hearing loss. Do not exceed the prescribed duration of treatment, and immediately report any changes in your hearing or symptoms of hearing loss to your doctor. Your doctor may recommend regular hearing tests during treatment.
To minimize the risk of a secondary infection, do not use this medication for longer than prescribed.
Antibiotics, including this medication, can cause diarrhea, which is usually mild. However, in rare cases, a severe form of diarrhea called Clostridioides difficile-associated diarrhea (CDAD) can occur, potentially leading to life-threatening bowel problems. CDAD may develop during or after treatment, sometimes several months later. If you experience stomach pain, cramps, or loose, watery, or bloody stools, contact your doctor promptly. Before treating diarrhea, consult your doctor for advice.
This medication is not approved for injection into the eye, as it can cause eye problems, including permanent vision loss, when administered via this route.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the potential benefits and risks with your doctor. For women of childbearing age, your doctor may require a pregnancy test before initiating treatment to confirm that you are not pregnant.
Overdose Information
Overdose Symptoms:
- Severe nephrotoxicity (kidney failure)
- Ototoxicity (hearing loss, tinnitus)
- Hypotension
- Red Man Syndrome (severe form)
What to Do:
Contact emergency services or poison control immediately (e.g., 1-800-222-1222). Treatment is supportive, including maintaining hydration, monitoring renal function, and potentially hemodialysis to remove vancomycin from the blood in severe cases.
Drug Interactions
Major Interactions
- Aminoglycosides (e.g., gentamicin, tobramycin, amikacin): Increased risk of nephrotoxicity and ototoxicity.
- Loop diuretics (e.g., furosemide): May increase risk of ototoxicity.
- Cisplatin: Increased risk of nephrotoxicity and ototoxicity.
- Cyclosporine: Increased risk of nephrotoxicity.
- Tacrolimus: Increased risk of nephrotoxicity.
- Polymyxins (e.g., colistin): Increased risk of nephrotoxicity.
Moderate Interactions
- Neuromuscular blockers (e.g., succinylcholine, rocuronium): Vancomycin may enhance or prolong the neuromuscular blockade.
- Metformin: Vancomycin may increase metformin concentrations (theoretical, due to shared renal transporters).
- Radiocontrast agents: Increased risk of nephrotoxicity when used concurrently or sequentially with vancomycin.
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: Vancomycin is primarily renally eliminated; baseline function is crucial for dosing and to monitor for nephrotoxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline for potential ototoxicity.
Timing: Prior to initiation of therapy.
Rationale: To assess for potential hematologic adverse effects (e.g., neutropenia, thrombocytopenia), though rare.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Prior to the 4th or 5th dose (at steady state) and then at least weekly for stable patients, or more frequently (e.g., 2-3 times/week) in unstable patients, those with changing renal function, or those on high doses.
Target: 10-15 mcg/mL for most infections; 15-20 mcg/mL for serious infections (e.g., endocarditis, osteomyelitis, meningitis, HAP/VAP, bacteremia, sepsis).
Action Threshold: Levels outside target range require dose adjustment; levels >20 mcg/mL increase risk of toxicity.
Frequency: At least 2-3 times per week, or daily in critically ill patients or those with unstable renal function.
Target: Within patient's baseline range; monitor for increases.
Action Threshold: Increase in SCr by âĨ0.5 mg/dL or âĨ50% from baseline (whichever is smaller) suggests acute kidney injury and requires dose adjustment or discontinuation.
Frequency: Daily patient assessment.
Target: Not applicable
Action Threshold: Report any new or worsening auditory/vestibular symptoms immediately.
Frequency: Daily
Target: Not applicable
Action Threshold: Redness, swelling, pain at infusion site; consider central line for prolonged therapy or high concentrations.
Symptom Monitoring
- Red Man Syndrome (flushing, rash, pruritus, urticaria, tachycardia, hypotension, muscle spasms, dyspnea, chest pain, angioedema) - typically during or shortly after infusion
- Ototoxicity (hearing loss, tinnitus, vertigo)
- Nephrotoxicity (decreased urine output, swelling, fatigue, nausea, confusion)
- Hypersensitivity reactions (rash, fever, chills, anaphylaxis)
- Neutropenia (fever, signs of infection)
- Thrombocytopenia (unusual bleeding or bruising)
- Phlebitis/irritation at injection site
Special Patient Groups
Pregnancy
Vancomycin is generally considered for use in pregnancy only when clearly needed and the benefits outweigh the potential risks. It crosses the placenta. Category C.
Trimester-Specific Risks:
Lactation
Vancomycin is excreted into breast milk in small amounts. While systemic absorption by the infant is low, potential risks include alteration of bowel flora, direct effects on the infant (e.g., allergic sensitization), and interference with culture results if the infant develops a fever. Use with caution; monitor infant for adverse effects. L3 (Moderate risk).
Pediatric Use
Dosing is weight-based and often requires therapeutic drug monitoring (trough levels) due to variable pharmacokinetics, especially in neonates and infants. Renal function must be closely monitored. Higher clearance rates in children may necessitate more frequent dosing.
Geriatric Use
Elderly patients are more likely to have age-related decreases in renal function, which necessitates careful dose adjustment and frequent monitoring of vancomycin trough levels and renal function. They may also be more susceptible to ototoxicity and nephrotoxicity.
Clinical Information
Clinical Pearls
- Always administer vancomycin IV infusions slowly over at least 60 minutes (or longer for doses >1g) to minimize the risk of Red Man Syndrome.
- Therapeutic drug monitoring (trough levels) is essential for optimizing efficacy and minimizing toxicity, especially for serious infections and in patients with unstable renal function.
- Maintain adequate hydration to reduce the risk of nephrotoxicity.
- Consider a central venous catheter for prolonged therapy or high concentrations to prevent phlebitis.
- Vancomycin is NOT absorbed orally for systemic infections; oral vancomycin is used only for Clostridioides difficile infection.
- The 15-20 mcg/mL trough target is for serious infections (e.g., MRSA bacteremia, endocarditis, meningitis, osteomyelitis, HAP/VAP); for less severe infections, 10-15 mcg/mL may be appropriate.
- Be vigilant for signs of nephrotoxicity (rising SCr) and ototoxicity (hearing changes, tinnitus).
Alternative Therapies
- Linezolid (for MRSA, VRE)
- Daptomycin (for MRSA, VRE)
- Ceftaroline (for MRSA)
- Tedizolid (for MRSA)
- Dalbavancin (for MRSA)
- Oritavancin (for MRSA)
- Quinupristin/Dalfopristin (for VRE, MRSA)
- Tigecycline (for MRSA, VRE, broad spectrum)